Wide Ranks

DGX

Quest Diagnostics Incorporated

163.32

Top Statistics
Market Cap 18 B Forward PE 16.79 Revenue Growth 8.40 %
Current Ratio 1.25 Trailing PE 21.92 Earnings Growth 1.50 %
Profit Margins 8.82 % Peg Ratio Dividend Yield 1.84 %
Enterprice / EBITA 13.60 Enterprise / Revenue 2.57 Price To Sales Trailing12 Months 1.91
Profitability
Profit Margins 8.82 % Operating Margins 14.19 %
Balance Sheet
Total Cash 764 M Total Cash Per Share 6.84 Total Debt 6 B
Total Debt To Equity 100.71 Current Ratio 1.25 Book Value Per Share 60.80
All Measures
Short Ratio 269.00 % Message Board Id finmb_361335 Shares Short Prior Month 2 M
Return On Equity 0.1322 City Secaucus Uuid 566b8ec0-af61-3aa2-ba40-9735eb85bfa2
Previous Close 162.27 First Trade Date Epoch Utc 850 M Book Value 60.80
Beta 0.8910 Total Debt 6 B Volume 670439
Price To Book 2.69 Last Split Date 1 B Fifty Two Week Low 123.04
Total Cash Per Share 6.84 Total Revenue 9 B Shares Short Previous Month Date 1 B
Target Median Price 166.50 Max Age 86400 Recommendation Mean 2.06
Sand P52 Week Change 0.3133 Operating Margins 14.19 % Last Dividend Value 0.7500
Target Mean Price 167.29 Net Income To Common 838 M Ask 163.07
Short Percent Of Float 0.0265 Implied Shares Outstanding 111 M Last Fiscal Year End 1 B
Trailing Peg Ratio 190.25 % Average Daily Volume10 Day 1 M Average Volume10days 1 M
Total Cash 764 M Next Fiscal Year End 1 B Revenue Per Share 85.74
Held Percent Insiders 0.0043 Ebitda Margins 18.92 % Dividend Rate 3.00
Trailing PE 21.92 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 162.27 Target Low Price 145.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 155.26 Open 162.05 Dividend Yield 1.84 %
State NJ Free Cashflow 853 M Return On Assets 0.0566
Time Zone Short Name EST Trailing Eps 7.45 Day Low 161.78
Address1 500 Plaza Drive Trailing Annual Dividend Rate 2.96 Price Hint 2
Shares Outstanding 111 M Target High Price 185.00 Website https://www.questdiagnostics.com
52 Week Change 0.1901 Average Volume 807573 Earnings Quarterly Growth 0.40 %
Forward Eps 9.76 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 102.30 % Last Split Factor 2:1 Regular Market Day High 163.88
Is_sp_500 True Profit Margins 8.82 % Debt To Equity 100.71
Fifty Two Week High 165.32 Day High 163.88 Shares Short 2 M
Regular Market Open 162.05 Industry Key diagnostics-research Bid 161.60
Earnings Growth 1.50 % Enterprise To Revenue 2.57 Revenue Growth 8.40 %
Shares Percent Shares Out 0.0232 Operating Cashflow 1 B Five Year Avg Dividend Yield 190.00 %
Currency USD Market Cap 18 B Time Zone Full Name America/New_York
Is_nasdaq_100 False Zip 07094 Payout Ratio 39.78 %
Quote Type EQUITY Industry Diagnostics & Research Ex Dividend Date 1 B
Regular Market Day Low 161.78 Held Percent Institutions 0.9159 Long Name Quest Diagnostics Incorporated
Current Price 163.32 Enterprise To Ebitda 13.60 Financial Currency USD
Trailing Annual Dividend Yield 1.82 % Current Ratio 1.25 Gross Margins 32.97 %
Industry Disp Diagnostics & Research Number Of Analyst Opinions 16 Country United States
Float Shares 110 M Two Hundred Day Average 143.33 Ir Website http://ir.questdiagnostics.com/phoenix.zhtml?c=82068&p=irol-stockquote
Enterprise Value 24 B Price To Sales Trailing12 Months 1.91 Forward PE 16.79
Regular Market Volume 670439 Last Dividend Date 1 B Ebitda 1 B
Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally.

The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.

The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions.

Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.